CA Stock MarketDetailed Quotes

MDNA Medicenna Therapeutics Corp

Watchlist
  • 1.000
  • 0.0000.00%
15min DelayMarket Closed Mar 20 16:00 ET
78.22MMarket Cap-2.70P/E (TTM)

Medicenna Therapeutics Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.70%-3.56M
-43.15%-5.61M
32.87%-2.33M
-28.47%-16.26M
-111.48%-4.85M
-10.09%-4.03M
10.95%-3.92M
-50.39%-3.47M
46.33%-12.66M
20.92%-2.29M
Net income from continuing operations
-4.30%-5.19M
-11.85%-4.16M
-27.08%-3.64M
-153.44%-25.47M
-260.58%-13.9M
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
Operating gains losses
515.07%449K
-2.71%-986K
94.26%-72K
257.48%8.24M
647.08%10.38M
102.12%73K
68.14%-960K
-646.43%-1.25M
-4,422.31%-5.23M
--1.39M
Depreciation and amortization
1,700.00%18K
1,000.00%11K
400.00%5K
0.00%4K
0.00%1K
0.00%1K
-50.00%1K
--1K
-89.47%4K
-87.50%1K
Remuneration paid in stock
295.60%629K
145.69%656K
46.28%433K
-11.82%1.21M
151.03%487K
-53.24%159K
-37.91%267K
-27.27%296K
-3.11%1.37M
-15.28%194K
Other non cashItems
--0
----
----
15.46%-984K
----
----
----
-163.64%-29K
-57.94%-1.16M
-49.50%-1.04M
Change In working capital
-24.79%540K
-343.44%-1.13M
148.16%943K
-69.25%741K
-180.35%-822K
18.09%718K
155.23%465K
-76.56%380K
230.69%2.41M
33.03%1.02M
-Change in receivables
-56.04%240K
137.42%58K
-123.02%-218K
36.31%1.68M
60.38%340K
-1.80%546K
90.50%-155K
-54.80%947K
414.03%1.23M
-56.38%212K
-Change in payables and accrued expense
74.42%300K
-291.94%-1.19M
304.76%1.16M
-179.47%-937K
-243.28%-1.16M
230.77%172K
-21.52%620K
-19.62%-567K
181.20%1.18M
186.57%811K
Cash from discontinued investing activities
Operating cash flow
11.70%-3.56M
-43.15%-5.61M
32.87%-2.33M
-28.47%-16.26M
-111.48%-4.85M
-10.09%-4.03M
10.95%-3.92M
-50.39%-3.47M
46.33%-12.66M
20.92%-2.29M
Investing cash flow
Cash flow from continuing investing activities
0
-2K
-31K
0
0
0
Net PPE purchase and sale
--0
---2K
---31K
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
---2K
---31K
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
1.91M
706K
20.9M
0
0
0
0
0
538.47%24.76M
-322.35%-189K
Net common stock issuance
--0
--0
--19.71M
--0
--0
--0
--0
--0
605.61%24.76M
--0
Proceeds from stock option exercised by employees
--1.91M
--706K
--1.18M
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--1.91M
--706K
--20.9M
--0
--0
--0
--0
--0
538.47%24.76M
-322.35%-189K
Net cash flow
Beginning cash position
18.45%30.43M
20.31%35.63M
-49.45%16.98M
63.60%33.6M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
-32.40%20.54M
54.55%36.15M
Current changes in cash
59.09%-1.65M
-25.20%-4.91M
634.54%18.54M
-234.35%-16.26M
-95.36%-4.85M
-14.34%-4.03M
-120.17%-3.92M
-159.39%-3.47M
225.34%12.1M
11.81%-2.48M
Effect of exchange rate changes
1,154.64%1.22M
-4,100.00%-294K
121.25%109K
-136.95%-354K
189.61%69K
128.96%97K
-100.55%-7K
-588.57%-513K
620.65%958K
-71.11%-77K
End cash Position
37.86%30M
18.45%30.43M
20.31%35.63M
-49.45%16.98M
-49.45%16.98M
-39.82%21.76M
-35.80%25.69M
53.42%29.62M
63.60%33.6M
63.60%33.6M
Free cash from
11.70%-3.56M
-43.20%-5.62M
31.98%-2.36M
-28.47%-16.26M
-111.48%-4.85M
-10.09%-4.03M
10.95%-3.92M
-50.39%-3.47M
46.33%-12.66M
20.92%-2.29M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.70%-3.56M-43.15%-5.61M32.87%-2.33M-28.47%-16.26M-111.48%-4.85M-10.09%-4.03M10.95%-3.92M-50.39%-3.47M46.33%-12.66M20.92%-2.29M
Net income from continuing operations -4.30%-5.19M-11.85%-4.16M-27.08%-3.64M-153.44%-25.47M-260.58%-13.9M-336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M
Operating gains losses 515.07%449K-2.71%-986K94.26%-72K257.48%8.24M647.08%10.38M102.12%73K68.14%-960K-646.43%-1.25M-4,422.31%-5.23M--1.39M
Depreciation and amortization 1,700.00%18K1,000.00%11K400.00%5K0.00%4K0.00%1K0.00%1K-50.00%1K--1K-89.47%4K-87.50%1K
Remuneration paid in stock 295.60%629K145.69%656K46.28%433K-11.82%1.21M151.03%487K-53.24%159K-37.91%267K-27.27%296K-3.11%1.37M-15.28%194K
Other non cashItems --0--------15.46%-984K-------------163.64%-29K-57.94%-1.16M-49.50%-1.04M
Change In working capital -24.79%540K-343.44%-1.13M148.16%943K-69.25%741K-180.35%-822K18.09%718K155.23%465K-76.56%380K230.69%2.41M33.03%1.02M
-Change in receivables -56.04%240K137.42%58K-123.02%-218K36.31%1.68M60.38%340K-1.80%546K90.50%-155K-54.80%947K414.03%1.23M-56.38%212K
-Change in payables and accrued expense 74.42%300K-291.94%-1.19M304.76%1.16M-179.47%-937K-243.28%-1.16M230.77%172K-21.52%620K-19.62%-567K181.20%1.18M186.57%811K
Cash from discontinued investing activities
Operating cash flow 11.70%-3.56M-43.15%-5.61M32.87%-2.33M-28.47%-16.26M-111.48%-4.85M-10.09%-4.03M10.95%-3.92M-50.39%-3.47M46.33%-12.66M20.92%-2.29M
Investing cash flow
Cash flow from continuing investing activities 0-2K-31K000
Net PPE purchase and sale --0---2K---31K----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow --0---2K---31K----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 1.91M706K20.9M00000538.47%24.76M-322.35%-189K
Net common stock issuance --0--0--19.71M--0--0--0--0--0605.61%24.76M--0
Proceeds from stock option exercised by employees --1.91M--706K--1.18M----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow --1.91M--706K--20.9M--0--0--0--0--0538.47%24.76M-322.35%-189K
Net cash flow
Beginning cash position 18.45%30.43M20.31%35.63M-49.45%16.98M63.60%33.6M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M-32.40%20.54M54.55%36.15M
Current changes in cash 59.09%-1.65M-25.20%-4.91M634.54%18.54M-234.35%-16.26M-95.36%-4.85M-14.34%-4.03M-120.17%-3.92M-159.39%-3.47M225.34%12.1M11.81%-2.48M
Effect of exchange rate changes 1,154.64%1.22M-4,100.00%-294K121.25%109K-136.95%-354K189.61%69K128.96%97K-100.55%-7K-588.57%-513K620.65%958K-71.11%-77K
End cash Position 37.86%30M18.45%30.43M20.31%35.63M-49.45%16.98M-49.45%16.98M-39.82%21.76M-35.80%25.69M53.42%29.62M63.60%33.6M63.60%33.6M
Free cash from 11.70%-3.56M-43.20%-5.62M31.98%-2.36M-28.47%-16.26M-111.48%-4.85M-10.09%-4.03M10.95%-3.92M-50.39%-3.47M46.33%-12.66M20.92%-2.29M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.